Private equity firm Advent International has completed its majority acquisition of Indian contract development and manufacturing organisation (CDMO) Suven Pharma. Advent acquired a 50.1% stake in Suven in December 2020 for INR 6,313 crore ($866 million) and will launch an open offer for an additional 26% of the company.
Advent acquires 50 1% in Suven Pharma, open offer for additional 26% ahead thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
Global private equity (PE) investor Advent International on Monday said it is acquiring a significant stake in Suven Pharmaceuticals from its promoters, the Jasti family.
nikkei.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nikkei.com Daily Mail and Mail on Sunday newspapers.